Serum neurofilament light chain rate of change in Alzheimer’s disease: potentials applications and notes of caution

Federico Massa, Riccardo Meli, Silvia Morbelli, Flavio Nobili, Matteo Pardini


Recent years have seen an increase of the use of imaging and fluid biomarkers as a key tool to help in the differential diagnosis of Alzheimer’s disease (AD), especially in its pre-dementia stages (1).